Brian Slater, a partner at Sterlington PLLC, serves as co-head of the firm’s Intellectual Property Practice and has experience as a lead trial lawyer. Slater’s clientele includes members from the pharmaceutical and biotechnical industries, and he is often relied upon to counsel technological innovators throughout their commercial and legal ventures.
Legal 500 Editorial commentary
Phone
+1 646 265 5642
Email
Profile

Accolades

New York Elite

Profile

Position

Partner and Co-Head, Intellectual Property

Career

Brian Slater is a Life Sciences and IP partner and Co-Head of Sterlington’s Intellectual Property practice. He is a lead trial lawyer who has represented pharmaceutical, biotechnology and other technology innovators, including Gilead, Merck, Novartis, Regeneron, and Sanofi, in high-stakes intellectual property disputes.

He has extensive experience as lead counsel in high-value Hatch-Waxman patent litigations representing branded pharmaceutical companies against generic drug challengers, as well as bet-the-company patent cases involving biologics. Leveraging his litigation experience and deep industry knowledge, Brian also counsels emerging and established life sciences companies on protecting, licensing, and monetizing their IP assets.

Content supplied by Sterlington PLLC

Key clients

  • Ipsen
  • PureTech

Work highlights

Lead counsel for Ipsen in relation to a Hatch-Waxman patent infringement case.